Neuro Peptide Comparison
Overview
A side-by-side comparison of the four neurocognitive compounds in this database — Semax, Selank, Noopept and Cerebrolysin — across chemistry, mechanism, research applications and handling. They range from defined heptapeptides to a small-molecule nootropic and a standardised peptide mixture, so the comparison is mostly about matching the tool to the research question.
Overview
| Parameter | Semax | Selank | Noopept | Cerebrolysin |
|---|---|---|---|---|
| Class | ACTH(4–10) analogue | Tuftsin analogue | Dipeptide nootropic | Brain-peptide cocktail |
| CAS | 80714-61-0 | 129954-34-3 | 157115-85-0 | N/A (mixture) |
| Molecular weight | ≈ 813.9 | ≈ 751.9 | 342.4 | 120–10,000 Da |
| Backbone | 7 aa (MEHFPGP) | 7 aa (TKPRPGP) | Peptide-derived small molecule | Mixture |
| Primary route | Intranasal | Intranasal | Oral / sublingual | IV / IM |
| Half-life | ≈ 30 min | ≈ 20 min | ≈ 2–5 h | ≈ 4–6 h |
Mechanism Comparison
Relative mechanistic emphasis (qualitative — established profiles, not fabricated figures):
| Mechanism | Semax | Selank | Noopept | Cerebrolysin |
|---|---|---|---|---|
| BDNF / NGF induction | Strong | Moderate | Strong | Strong |
| TrkB / TrkC signalling | Direct | Indirect | Direct | Direct (multiple) |
| GABAergic modulation | — | Strong | — | Indirect |
| AMPA-receptor modulation | — | — | Strong | Indirect |
| Enkephalinase inhibition | — | Yes | — | — |
| Neurogenesis | Some | — | Some | Strong |
Research Applications
| Application | Semax | Selank | Noopept | Cerebrolysin |
|---|---|---|---|---|
| Anxiety | — | Primary | Minor | — |
| Cognitive enhancement | Strong | Moderate | Strong | Strong |
| Neuroprotection | Strong | Some | Strong | Strong |
| Stroke recovery | Strong | — | Some | Strong |
| Neurodegeneration | Some | — | Some | Strong |
| Immunomodulation | — | Strong | — | — |
Formulation & Handling
| Parameter | Semax | Selank | Noopept | Cerebrolysin |
|---|---|---|---|---|
| Form | Lyophilized powder | Lyophilized powder | Crystalline powder | Sterile solution |
| Solvent | Bacteriostatic water | Bacteriostatic water | Water / saline | Pre-mixed |
| Storage (stock) | −20°C | −20°C | 2–8°C | 15–25°C sealed |
| Reconstituted storage | 2–8°C, ~7 d | 2–8°C, ~7 d | 2–8°C, ~2 wk | Use promptly |
| Light sensitivity | Moderate | Moderate | Low | Low |
Safety Comparison
Published research observations; all are for research use only, not for human or veterinary use.
| Category | Semax | Selank | Noopept | Cerebrolysin |
|---|---|---|---|---|
| Tolerability | Good | Good | Good | Good |
| Sedation | None | None (anxiolytic without sedation) | None | None |
| Origin | Synthetic | Synthetic | Synthetic | Porcine-derived |
Selection Guide
Choose Semax when
Neurotrophic induction and stroke / cognition neuroprotection are the focus, with intranasal delivery.
Choose Selank when
Anxiolytic (without sedation) or immunomodulatory endpoints are primary.
Choose Noopept when
An orally active nootropic with AMPA / BDNF mechanisms is wanted (note: small molecule).
Choose Cerebrolysin when
A broad neurotrophic-cocktail approach for neurodegeneration or injury research is the goal.
Selected References
- Semax, Selank, Noopept and Cerebrolysin neuroprotection and cognition research literature.
- Reviews of regulatory peptides and nootropic compounds in CNS research.
Quality & Supply
- Peptides HPLC ≥ 98% with a Certificate of Analysis; Noopept ≥ 99% (NMR + MS)
- Cerebrolysin supplied as standardised sterile ampoules with batch documentation
- Research samples through to bulk, with worldwide delivery
- Custom quantities and packaging on request
Need Neuro Peptide Comparison — sample or bulk?
HPLC-verified, COA per batch. Tell us the quantity you need.
